ACM
ADAR1 Capital Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
57,466
+42,866
| +294% | +$872K | 0.18% | 72 |
|
|
2025
Q1 | $265K | Buy |
+14,600
| New | +$265K | 0.05% | 128 |
|
|
2024
Q4 | – | Sell |
-5,000
| Closed | -$170K | – | 222 |
|
|
2024
Q3 | $170K | Buy |
5,000
+4,697
| +1,550% | +$160K | 0.03% | 156 |
|
|
2024
Q2 | $11.2K | Buy |
+303
| New | +$11.2K | ﹤0.01% | 213 |
|